These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1053865)

  • 1. Recent advances in hemophilia. Part III. Discussion paper: The Red Cross program.
    Greenwalt TJ
    Ann N Y Acad Sci; 1975 Jan; 240():208-12. PubMed ID: 1053865
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of large-scale fractionation methods. II. Isolation of a factor IX concentrate (prothrombin complex) for clinical use.
    Wickerhauser M; Sgouris JT
    Vox Sang; 1972; 22(2):137-60. PubMed ID: 5013242
    [No Abstract]   [Full Text] [Related]  

  • 3. Affinity chromatography of coagulation factors II, VIII, IX and X on matrix-bound phospholipid vesicles.
    Andersson LO; Thuy LP; Brown JE
    Thromb Res; 1981 Sep; 23(6):481-9. PubMed ID: 6798706
    [No Abstract]   [Full Text] [Related]  

  • 4. [Technic of obtaining the antihemophilic factors VIII and IX and their clinical application].
    Triginer J; Vila M; Vicente Arangüena P
    Sangre (Barc); 1979; 24(5-C):937-41. PubMed ID: 121169
    [No Abstract]   [Full Text] [Related]  

  • 5. Concentration of hepatitis-B antigen from clinical preparations of II, VII, IX and X by polyethylene glycol, to enhance detection and removal.
    Johnson AJ
    Ann N Y Acad Sci; 1975 Jan; 240():162-4. PubMed ID: 234215
    [No Abstract]   [Full Text] [Related]  

  • 6. THE FATE OF PROTHROMBIN AND FACTORS VIII, IX AND X TRANSFUSED TO PATIENTS DEFICIENT IN THESE FACTORS.
    BIGGS R; DENSON KW
    Br J Haematol; 1963 Oct; 9():532-47. PubMed ID: 14076135
    [No Abstract]   [Full Text] [Related]  

  • 7. A therapeutic concentrate of coagulation factors II, IX and X from citrated, factor VIII-depleted plasma.
    Middleton SM; Bennett IH; Smith JK
    Vox Sang; 1973 May; 24(5):441-56. PubMed ID: 4691239
    [No Abstract]   [Full Text] [Related]  

  • 8. Cryoprecipitate.
    Armstrong D
    S Afr Med J; 1975 Jul; 49(31):1245-7. PubMed ID: 1154189
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent advances in hemophilia. Part III. Discussion paper: Other points on the problem of blood resources.
    Surgenor DM
    Ann N Y Acad Sci; 1975 Jan; 240():213-4. PubMed ID: 1053866
    [No Abstract]   [Full Text] [Related]  

  • 10. The hemophiliac's demand on blood resources: the magnitude of the problem.
    Stengle JM
    Ann N Y Acad Sci; 1975 Jan; 240():155-61. PubMed ID: 1053861
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of large-scale fractionation methods. 3. Preparation of a factor VIII concentrate of intermediate-purity.
    James HL; Wickerhauser M
    Vox Sang; 1972; 23(5):402-12. PubMed ID: 5077739
    [No Abstract]   [Full Text] [Related]  

  • 12. Improved procedures for the purification of selected vitamin K-dependent proteins.
    Novoa E; Seegers WH; Hassouna HI
    Prep Biochem; 1976; 6(5):307-38. PubMed ID: 787972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of hepatitis B surface antigen (HBsAg) from plasma fractions.
    Johnson AJ; Semar M; Newman J; Harris RB; Brandt D; Middleton S; Smith J
    J Lab Clin Med; 1976 Jul; 88(1):91-101. PubMed ID: 932537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modern treatment of hemophilia: from the shadows towards the light.
    Mannucci PM
    Thromb Haemost; 1993 Jul; 70(1):17-23. PubMed ID: 8236096
    [No Abstract]   [Full Text] [Related]  

  • 15. [Transfusion therapy of hemophilia A and B].
    Egli H
    Bibl Haematol; 1967; 27():204-10. PubMed ID: 5595089
    [No Abstract]   [Full Text] [Related]  

  • 16. The preparation of the factors IX, II, and X concentrate by means of DEAE cellulos and its therapeutic effectiveness.
    Uszyński L; Poszwiński P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(5):591-4. PubMed ID: 54310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outbreaks of hepatitis A and emergence of new AIDS-associated agents: the need to add terminal 100 degrees C dry-heat sterilization to factor VIII and factor IX concentrates.
    Guillaume TA
    Vox Sang; 1993; 65(2):158. PubMed ID: 8212671
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatitis in hemophilia].
    Eggeling B; Sennekamp J; Brackmann HH; Werner I
    Schweiz Med Wochenschr; 1974 Sep; 104(36):1250-5. PubMed ID: 4445853
    [No Abstract]   [Full Text] [Related]  

  • 19. [The P.P.S.B. coagulant fraction].
    Soulier JP; Steinbuch M
    Nouv Presse Med; 1975 Oct; 4(36):2581-4. PubMed ID: 812061
    [No Abstract]   [Full Text] [Related]  

  • 20. The isolation of prothrombin, Factor IX and Factor X from human Factor IX concentrates.
    Modi GJ; Blajchman MA; Ofosu FA
    Thromb Res; 1984 Dec; 36(6):537-47. PubMed ID: 6084874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.